Lymphangiogenesis and its regulation in human neuroblastoma

Biochemical and Biophysical Research Communications

Volumn 352, Issue 2, 2007, Pages 571-577

  Lagodny, Jeanette ^a   Jüttner, Eva ^a   Kayser, Gian ^a   Niemeyer, Charlotte Marie ^a   Rössler, Jochen ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Lymphangiogenesis; Methylation; Neuroblastoma; Retinoic acid; siRNA; VEGF C

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MESSENGER RNA; MONOCLONAL ANTIBODY; RETINOIC ACID; SMALL INTERFERING RNA; VASCULOTROPIN C; VASCULOTROPIN D;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHANGIOGENESIS; METHYLATION; NEUROBLASTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UPREGULATION;

HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; NEUROBLASTOMA; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 33751522642     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.11.062     Document Type: Article

References (37)

1. Schwab M., Westermann F., Hero B., and Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology. Lancet. Oncol. 4 (2003) 472-480
2. Maris J.M., and Matthay K.K. Molecular biology of neuroblastoma. J. Clin. Oncol. 17 (1999) 2264-2279
3. Chlenski A., Liu S., and Cohn S.L. The regulation of angiogenesis in neuroblastoma. Cancer Lett. 197 (2003) 47-52
4. Meitar D., Crawford S.E., Rademaker A.W., and Cohn S.L. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J. Clin. Oncol. 14 (1996) 405-414
5. Rossler J., Breit S., Havers W., and Schweigerer L. Vascular endothelial growth factor expression in human neuroblastoma: up-regulation by hypoxia. Int. J. Cancer 81 (1999) 113-117
6. Pavlakovic H., Von S., Rossler V.J., Koscielniak E., Havers W., and Schweigerer L. Quantification of angiogenesis stimulators in children with solid malignancies. Int. J. Cancer 92 (2001) 756-760
7. Ribatti D., and Ponzoni M. Antiangiogenic strategies in neuroblastoma. Cancer Treat. Rev. 31 (2005) 27-34
8. Shusterman S., and Maris J.M. Prospects for therapeutic inhibition of neuroblastoma angiogenesis. Cancer Lett. 228 (2005) 171-179
9. Breiteneder-Geleff S., Soleiman A., Horvat R., Amann G., Kowalski H., and Kerjaschki D. [Podoplanin-a specific marker for lymphatic endothelium expressed in angiosarcoma]. Verh. Dtsch. Ges. Pathol. 83 (1999) 270-275
10. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., Jones M., and Jackson D.G. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144 (1999) 789-801
11. Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., Jackson D.G., Nishikawa S., Kubo H., and Achen M.G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7 (2001) 186-191
12. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., Riccardi L., Alitalo K., Claffey K., and Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7 (2001) 192-198
13. Alam A., Herault J.P., Barron P., Favier B., Fons P., Delesque-Touchard N., Senegas I., Laboudie P., Bonnin J., Cassan C., Savi P., Ruggeri B., Carmeliet P., Bono F., and Herbert J.M. Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity. Biochem. Biophys. Res. Commun. 324 (2004) 909-915
14. Schmid K., Birner P., Gravenhorst V., End A., and Geleff S. Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung. Am. .J. Surg. Pathol. 29 (2005) 324-328
15. Beasley N.J., Prevo R., Banerji S., Leek R.D., Moore J., van Trappen P., Cox G., Harris A.L., and Jackson D.G. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 62 (2002) 1315-1320
16. He Y., Kozaki K., Karpanen T., Koshikawa K., Yla-Herttuala S., Takahashi T., and Alitalo K. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl. Cancer Inst. 94 (2002) 819-825
17. Karpanen T., and Alitalo K. Lymphatic vessels as targets of tumor therapy?. J. Exp. Med. 194 (2001) F37-F42
18. Schacht V., Dadras S.S., Johnson L.A., Jackson D.G., Hong Y.K., and Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am. J. Pathol. 166 (2005) 913-921
19. Tuschl T. Expanding small RNA interference. Nat. Biotechnol. 20 (2002) 446-448
20. Tuschl T. RNA interference and small interfering RNAs. Chem. Biochem. 2 (2001) 239-245
21. Kayser G., Baumhakel J.D., Szoke T., Trojan I., Riede U., Werner M., and Kayser K. Vascular diffusion density and survival of patients with primary lung carcinomas. Virchows Arch. 442 (2003) 462-467
22. Canete A., Navarro S., Bermudez J., Pellin A., Castel V., and Llombart-Bosch A. Angiogenesis in neuroblastoma: relationship to survival and other prognostic factors in a cohort of neuroblastoma patients. J. Clin. Oncol. 18 (2000) 27-34
23. Wong S.Y., Haack H., Crowley D., Barry M., Bronson R.T., and Hynes R.O. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res. 65 (2005) 9789-9798
24. Alitalo K., Mohla S., and Ruoslahti E. Lymphangiogenesis and cancer: meeting report. Cancer Res. 64 (2004) 9225-9229
25. Achen M.G., McColl B.K., and Stacker S.A. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7 (2005) 121-127
26. Eggert A., Ikegaki N., Kwiatkowski J., Zhao H., Brodeur G.M., and Himelstein B.P. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin. Cancer Res. 6 (2000) 1900-1908
27. Reynolds C.P., Matthay K.K., Villablanca J.G., and Maurer B.J. Retinoid therapy of high-risk neuroblastoma. Cancer Lett. 197 (2003) 185-192
28. Matthay K.K., Villablanca J.G., Seeger R.C., Stram D.O., Harris R.E., Ramsay N.K., Swift P., Shimada H., Black C.T., Brodeur G.M., Gerbing R.B., and Reynolds C.P. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N. Engl. J. Med. 341 (1999) 1165-1173
29. Rossler J., Zambrzycka I., Lagodny J., Kontny U., and Niemeyer C.M. Effect of STI-571 (imatinib mesylate) in combination with retinoic acid and gamma-irradiation on viability of neuroblastoma cells. Biochem. Biophys. Res. Commun. 342 (2006) 1405-1412
30. Bird A.P., and Wolffe A.P. Methylation-induced repression-belts, -braces, and -chromatin. Cell 99 (1999) 451-454
31. Juttermann R., Li E., and Jaenisch R. Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl. Acad. Sci. USA 91 (1994) 11797-11801
32. Bartolucci S., Estenoz M., Longo A., Santoro B., Momparler R.L., Rossi M., and Augusti-Tocco G. 5-Aza-2′-deoxycytidine as inducer of differentiation and growth inhibition in mouse neuroblastoma cells. Cell Differ. Dev. 27 (1989) 47-55
33. Bartolucci S., Estenoz M., de F., Carpinelli V.P., Colucci G.L., Augusti T.G., and Rossi M. Effect of cytidine analogs on cell growth and differentiation on a human neuroblastoma line. Cell Biophys. 15 (1989) 67-77
34. Carpinelli P., Granata F., Augusti-Tocco G., Rossi M., and Bartolucci S. Antiproliferative effects and DNA hypomethylation by 5-aza-2′-deoxycytidine in human neuroblastoma cell lines. Anticancer Drugs 4 (1993) 629-635
35. Detwiller K.Y., Fernando N.T., Segal N.H., Ryeom S.W., D'Amore P.A., and Yoon S.S. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Cancer Res. 65 (2005) 5881-5889
36. Schiffelers R.M., van R., and Storm I.G. siRNA-mediated inhibition of angiogenesis. Expert. Opin. Biol. Ther. 5 (2005) 359-368
37. Rossler J., and Lagodny J. Blood and lymph vessels in embryonic tumors. Hematol. Oncol. 23 (2005) 94-101